QUARTERLY REPORT

Q3 2025 — Form 10-Q

Q3 2025PDF · 34 pages443 KB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ 	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the quarterly period ended September 30, 2025
☐ 	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the transition period from ___________ to ___________
Commission File Number 001-03761
TEXAS INSTRUMENTS INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Delaware 	75-0289970
(State of Incorporation) 	(I.R.S. Employer Identification No.)
12500 TI Boulevard, Dallas, Texas 	75243
(Address of principal executive offices) 	(Zip Code)
Registrant’s telephone number, including area code 214-479-3773
Securities registered pursuant to Section 12(b) of the Act:
Title of each class 	Trading Symbol(s) 	Name of each exchange on which registered
Common Stock, par value $1.00 	TXN 	The Nasdaq Global Select Market
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to
Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was
required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,”
and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer 	☒ 	Accelerated filer 	☐
Non-accelerated filer 	☐ 	Smaller reporting company 	☐
Emerging growth company 	☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
908,623,020
Number of shares of Registrant’s common stock outstanding as of
October 14, 2025

-- 1 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
PART I - FINANCIAL INFORMATION
ITEM 1. Financial statements
For Three Months Ended 	For Nine Months Ended
Consolidated Statements of Income 	September 30, 	September 30,
(In millions, except per-share amounts) 	2025 	2024 	2025 	2024
Revenue 	$ 	4,742 $ 	4,151 $ 	13,259 $ 	11,634
Cost of revenue (COR) 	2,019 	1,677 	5,648 	4,854
Gross profit 	2,723 	2,474 	7,611 	6,780
Research and development (R&D) 	518 	492 	1,562 	1,468
Selling, general and administrative (SG&A) 	457 	428 	1,414 	1,348
Restructuring charges/other 	85 	— 	85 	(124)
Operating profit 	1,663 	1,554 	4,550 	4,088
Other income (expense), net (OI&E) 	62 	131 	190 	384
Interest and debt expense 	141 	131 	402 	378
Income before income taxes 	1,584 	1,554 	4,338 	4,094
Provision for income taxes 	220 	192 	500 	500
Net income 	$ 	1,364 $ 	1,362 $ 	3,838 $ 	3,594
Earnings per common share (EPS):
Basic 	$ 	1.49 $ 	1.48 $ 	4.20 $ 	3.92
Diluted 	$ 	1.48 $ 	1.47 $ 	4.18 $ 	3.89
Average shares outstanding:
Basic 	909 	913 	909 	912
Diluted 	914 	920 	914 	919
A portion of net income is allocated to unvested restricted stock units (RSUs) on which we pay dividend equivalents. Diluted EPS is
calculated using the following:
Net income 	$ 	1,364 $ 	1,362 $ 	3,838 $ 	3,594
Income allocated to RSUs 	(8) 	(7) 	(21) 	(18)
Income allocated to common stock for diluted EPS 	$ 	1,356 $ 	1,355 $ 	3,817 $ 	3,576
See accompanying notes.
2

-- 2 of 34 --

For Three Months Ended 	For Nine Months Ended
Consolidated Statements of Comprehensive Income 	September 30, 	September 30,
(In millions) 	2025 	2024 	2025 	2024
Net income 	$ 	1,364 $ 	1,362 $ 	3,838 $ 	3,594
Other comprehensive income (loss)
Net actuarial losses of defined benefit plans:
Adjustments, net of tax effect of ($1) and $5; $6 and $2 	1 	(11) 	(19) 	(5)
Recognized within net income, net of tax effect of ($1) and ($1); ($3)
and ($3) 	5 	2 	11 	7
Prior service cost (credit) of defined benefit plans:
Recognized within net income, net of tax effect of $0 and $0; $0 and $0 	— 	1 	— 	1
Derivative instruments:
Change in fair value, net of tax effect of $0 and $0; $0 and $0 	— 	— 	— 	1
Available-for-sale investments:
Unrealized gains (losses), net of tax effect of $1 and ($4); $1 and ($2) 	1 	13 	(1) 	6
Other comprehensive income (loss), net of taxes 	7 	5 	(9) 	10
Total comprehensive income 	$ 	1,371 $ 	1,367 $ 	3,829 $ 	3,604
See accompanying notes.
3

-- 3 of 34 --

September 30, 	December 31,
Consolidated Balance Sheets 	2025 	2024
(In millions, except par value)
Assets
Current assets:
Cash and cash equivalents 	$ 	3,311 $ 	3,200
Short-term investments 	1,875 	4,380
Accounts receivable, net of allowances of ($21) and ($21) 	2,062 	1,719
Raw materials 	431 	395
Work in process 	2,460 	2,214
Finished goods 	1,938 	1,918
Inventories 	4,829 	4,527
Prepaid expenses and other current assets 	1,799 	1,200
Total current assets 	13,876 	15,026
Property, plant and equipment at cost 	17,314 	15,254
Accumulated depreciation 	(4,966) 	(3,907)
Property, plant and equipment 	12,348 	11,347
Goodwill 	4,362 	4,362
Deferred tax assets 	1,089 	936
Capitalized software licenses 	237 	257
Overfunded retirement plans 	251 	233
Other long-term assets 	2,841 	3,348
Total assets 	$ 	35,004 $ 	35,509
Liabilities and stockholders’ equity
Current liabilities:
Current portion of long-term debt 	$ 	500 $ 	750
Accounts payable 	779 	820
Accrued compensation 	724 	839
Income taxes payable 	79 	159
Accrued expenses and other liabilities 	1,036 	1,075
Total current liabilities 	3,118 	3,643
Long-term debt 	13,546 	12,846
Underfunded retirement plans 	125 	110
Deferred tax liabilities 	60 	53
Other long-term liabilities 	1,528 	1,954
Total liabilities 	18,377 	18,606
Stockholders’ equity:
Preferred stock, $25 par value. Shares authorized – 10; none issued 	— 	—
Common stock, $1 par value. Shares authorized – 2,400; shares issued – 1,741 	1,741 	1,741
Paid-in capital 	4,410 	3,935
Retained earnings 	52,369 	52,262
Treasury common stock at cost
Shares: September 30, 2025 – 832; December 31, 2024 – 830 	(41,744) 	(40,895)
Accumulated other comprehensive income (loss), net of taxes (AOCI) 	(149) 	(140)
Total stockholders’ equity 	16,627 	16,903
Total liabilities and stockholders’ equity 	$ 	35,004 $ 	35,509
See accompanying notes.
4

-- 4 of 34 --

For Nine Months Ended
Consolidated Statements of Cash Flows 	September 30,
(In millions) 	2025 	2024
Cash flows from operating activities
Net income 	$ 	3,838 $ 	3,594
Adjustments to net income:
Depreciation 	1,381 	1,092
Amortization of capitalized software 	61 	53
Stock compensation 	338 	309
Gains on sales of assets 	— 	(126)
Deferred taxes 	(134) 	(189)
Increase (decrease) from changes in:
Accounts receivable 	(343) 	(75)
Inventories 	(302) 	(297)
Prepaid expenses and other current assets 	2 	(69)
Accounts payable and accrued expenses 	57 	38
Accrued compensation 	(134) 	(127)
Income taxes payable 	168 	487
Changes in funded status of retirement plans 	(14) 	2
Other 	(19) 	(372)
Cash flows from operating activities 	4,899 	4,320
Cash flows from investing activities
Capital expenditures 	(3,625) 	(3,628)
Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives 	335 	—
Proceeds from asset sales 	1 	194
Purchases of short-term investments 	(2,644) 	(8,807)
Proceeds from short-term investments 	5,198 	8,461
Other 	(28) 	(36)
Cash flows from investing activities 	(763) 	(3,816)
Cash flows from financing activities
Proceeds from issuance of long-term debt 	1,199 	2,980
Repayment of debt 	(750) 	(300)
Dividends paid 	(3,709) 	(3,555)
Stock repurchases 	(1,074) 	(392)
Proceeds from common stock transactions 	358 	430
Other 	(49) 	(42)
Cash flows from financing activities 	(4,025) 	(879)
Net change in cash and cash equivalents 	111 	(375)
Cash and cash equivalents at beginning of period 	3,200 	2,964
Cash and cash equivalents at end of period 	$ 	3,311 $ 	2,589
Supplemental cash flow information
Investment tax credit (ITC) used to reduce income taxes payable 	$ 	246 $ 	532
Proceeds from CHIPS Act incentives 	335 	—
Total cash benefit related to the CHIPS Act 	$ 	581 $ 	532
See accompanying notes.
5

-- 5 of 34 --

Notes to financial statements
1. Description of business, including segment and geographic area information
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. We have two
reportable segments, Analog and Embedded Processing, each of which represents groups of products that have similar design and
development requirements, product characteristics and manufacturing processes. Our segments reflect how our chief operating decision
maker (CODM), which is our chief executive officer, allocates resources and measures results.
• Analog semiconductors change real-world signals, such as sound, temperature, pressure or images, by conditioning them, amplifying
them and often converting them to a stream of digital data that can be processed by other semiconductors, such as embedded
processors. Analog semiconductors are also used to manage power in all electronic equipment by converting, distributing, storing,
discharging, isolating and measuring electrical energy, whether the equipment is plugged into a wall or using a battery. Our Analog
segment consists of two major product lines: Power and Signal Chain.
• Embedded Processing products are the digital “brains” of many types of electronic equipment. They are designed to handle specific
tasks and can be optimized for various combinations of performance, power and cost, depending on the application.
We report the results of our remaining business activities in Other. Other includes operating segments that do not meet the quantitative
thresholds for individually reportable segments and cannot be aggregated with other operating segments. Other includes DLP products,
calculators and custom ASIC products.
In Other, we also include items that are not used in evaluating the results of or in allocating resources to our segments. Examples of these
items include acquisition, integration and restructuring charges, and certain corporate-level items, such as litigation expenses, environmental
costs, insurance settlements, and gains and losses from other activities, including asset dispositions. We allocate the remainder of our
expenses associated with corporate activities to our operating segments based on specific methodologies, such as percentage of operating
expenses or headcount.
Costs incurred by our centralized manufacturing and support organizations, including depreciation, are charged to the operating segments,
including those in Other, on a per-unit basis. Consequently, depreciation expense is not an independently identifiable component within the
segments’ results and, therefore, is not provided.
With the exception of goodwill, we do not identify or allocate assets by operating segment, nor does the CODM evaluate operating segments
using discrete asset information. We have no material intersegment revenue. The accounting policies of the segments are consistent with
those described in the significant accounting policies and practices.
Segment information
For Three Months Ended September 30,
2025 	2024
Analog Embedded
Processing 	Other 	Total 	Analog Embedded
Processing 	Other 	Total
Revenue 	$ 	3,729 $ 	709 $ 	304 $ 	4,742 $ 	3,223 $ 	653 $ 	275 $ 	4,151
Cost of revenue 	1,543 	373 	103 	2,019 	1,253 	328 	96 	1,677
Gross profit 	2,186 	336 	201 	2,723 	1,970 	325 	179 	2,474
R&D 	371 	127 	20 	518 	350 	124 	18 	492
SG&A 	329 	101 	27 	457 	304 	92 	32 	428
Restructuring
charges/other 	— 	— 	85 	85 	— 	— 	— 	—
Operating profit 	$ 	1,486 $ 	108 $ 	69 $ 	1,663 $ 	1,316 $ 	109 $ 	129 $ 	1,554
®
6

-- 6 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
For Nine Months Ended September 30,
2025 	2024
Analog Embedded
Processing 	Other 	Total 	Analog Embedded
Processing 	Other 	Total
Revenue 	$ 	10,391 $ 	2,035 $ 	833 $ 	13,259 $ 	8,987 $ 	1,920 $ 	727 $ 	11,634
Cost of revenue 	4,234 	1,113 	301 	5,648 	3,600 	981 	273 	4,854
Gross profit 	6,157 	922 	532 	7,611 	5,387 	939 	454 	6,780
R&D 	1,123 	380 	59 	1,562 	1,059 	355 	54 	1,468
SG&A 	1,017 	309 	88 	1,414 	957 	290 	101 	1,348
Restructuring
charges/other 	— 	— 	85 	85 	— 	— 	(124) 	(124)
Operating profit 	$ 	4,017 $ 	233 $ 	300 $ 	4,550 $ 	3,371 $ 	294 $ 	423 $ 	4,088
Geographic area information
Our estimate for revenue based on the geographic location of our end customers’ headquarters, which represents where critical decisions
are made, is as follows:
For Three Months Ended 	For Nine Months Ended
September 30, 	September 30,
2025 	2024 	2025 	2024
Revenue:
United States 	$ 1,859 	39 % $ 1,639 	39 % $ 5,084 	38 % $ 4,335 	37 %
China 	1,019 	21 	823 	20 	2,830 	21 	2,191 	19
Rest of Asia 	505 	11 	431 	10 	1,430 	11 	1,249 	11
Europe, Middle East and Africa (a) 	972 	20 	880 	21 	2,799 	21 	2,733 	23
Japan 	313 	7 	313 	8 	883 	7 	935 	8
Rest of world 	74 	2 	65 	2 	233 	2 	191 	2
Total revenue 	$ 4,742 	100 % $ 4,151 	100 % $ 13,259 	100 % $ 11,634 	100 %
(a) Revenue from end customers headquartered in Germany was 10% and 11% in the third quarters of 2025 and 2024, respectively, and
10% and 12% in the first nine months of 2025 and 2024, respectively.
2. Basis of presentation and significant accounting policies and practices
Basis of presentation
The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States
(GAAP) and on the same basis as the audited financial statements included in our annual report on Form 10-K for the year ended December
31, 2024. The Consolidated Statements of Income, Comprehensive Income and Cash Flows for the periods ended September 30, 2025 and
2024, and the Consolidated Balance Sheet as of September 30, 2025, are not audited but reflect all adjustments that are of a normal
recurring nature and are necessary for a fair statement of the results of the periods shown. Certain information and note disclosures normally
included in annual consolidated financial statements have been omitted pursuant to the rules and regulations of the U.S. Securities and
Exchange Commission. Because the consolidated interim financial statements do not include all of the information and notes required by
GAAP for a complete set of financial statements, they should be read in conjunction with the audited consolidated financial statements and
notes included in our annual report on Form 10-K for the year ended December 31, 2024. The results for the three- and nine-month periods
are not necessarily indicative of a full year’s results.
7

-- 7 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Significant accounting policies and practices
Earnings per share (EPS)
We use the two-class method for calculating EPS because the restricted stock units (RSUs) we grant are participating securities containing
nonforfeitable rights to receive dividend equivalents. Under the two-class method, a portion of net income is allocated to RSUs and excluded
from the calculation of income allocated to common stock.
Computation and reconciliation of earnings per common share are as follows:
For Three Months Ended September 30,
2025 	2024
Net Income 	Shares 	EPS 	Net Income 	Shares 	EPS
Basic EPS:
Net income 	$ 	1,364 	$ 	1,362
Income allocated to RSUs 	(8) 	(7)
Income allocated to common stock 	$ 	1,356 	909 $ 	1.49 $ 	1,355 	913 $ 	1.48
Dilutive effect of stock compensation plans 	5 	7
Diluted EPS:
Net income 	$ 	1,364 	$ 	1,362
Income allocated to RSUs 	(8) 	(7)
Income allocated to common stock 	$ 	1,356 	914 $ 	1.48 $ 	1,355 	920 $ 	1.47
For Nine Months Ended September 30,
2025 	2024
Net Income 	Shares 	EPS 	Net Income 	Shares 	EPS
Basic EPS:
Net income 	$ 	3,838 	$ 	3,594
Income allocated to RSUs 	(21) 	(18)
Income allocated to common stock 	$ 	3,817 	909 $ 	4.20 $ 	3,576 	912 $ 	3.92
Dilutive effect of stock compensation plans 	5 	7
Diluted EPS:
Net income 	$ 	3,838 	$ 	3,594
Income allocated to RSUs 	(21) 	(18)
Income allocated to common stock 	$ 	3,817 	914 $ 	4.18 $ 	3,576 	919 $ 	3.89
Potentially dilutive securities representing 4 million and 3 million shares of common stock that were outstanding during the third quarters of
2025 and 2024, respectively, and 10 million and 9 million shares outstanding during the first nine months of 2025 and 2024, respectively,
were excluded from the computation of diluted earnings per common share during these periods because their effect would have been anti-
dilutive.
Derivatives and hedging
We use derivative financial instruments to manage exposure to foreign exchange risk. These instruments are primarily forward foreign
currency exchange contracts, which are used as economic hedges to reduce the earnings impact that exchange rate fluctuations may have
on our non-U.S. dollar net balance sheet exposures. Gains and losses from changes in the fair value of these forward foreign currency
exchange contracts are credited or charged to OI&E. We do not apply hedge accounting to our foreign currency derivative instruments.
8

-- 8 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
We are exposed to variability in compensation charges related to certain deferred compensation obligations to employees. We use total
return swaps to economically hedge this exposure and offset the related compensation expense, recognizing changes in the fair value of the
swaps and the related deferred compensation liabilities in SG&A.
In connection with the issuance of long-term debt, we may use financial derivatives such as treasury-rate lock agreements that are
recognized in AOCI and amortized over the life of the related debt.
The results of these derivative transactions were not material. We do not use derivatives for speculative or trading purposes.
Fair values of financial instruments
The fair values of our derivative financial instruments were not material as of September 30, 2025. Our investments in cash equivalents,
short-term investments and certain long-term investments, as well as our deferred compensation liabilities, are carried at fair value. The
carrying values for other current financial assets and liabilities, such as accounts receivable and accounts payable, approximate fair value
due to the short maturity of such instruments. As of September 30, 2025, the carrying value of long-term debt, including the current portion,
was $14.05 billion, and the estimated fair value was $13.30 billion. The estimated fair value is measured using broker-dealer quotes, which
are Level 2 inputs. See Note 4 for a description of fair value and the definition of Level 2 inputs.
Changes in accounting standards – standards not yet adopted
ASU 2023-09, Improvements to Income Tax Disclosures
This standard requires disaggregated income tax disclosures on effective tax rate reconciliations and income taxes paid. ASU 2023-09 is
effective for annual reporting periods beginning after December 15, 2024. As a result of adopting this guidance, our income tax disclosures
will be expanded.
ASU 2024-03, Disaggregation of Income Statement Expenses
This standard requires disaggregated disclosures of certain expense captions into specified categories in the notes to the financial
statements. ASU 2024-03 is effective for annual reporting periods beginning after December 15, 2026. We are currently evaluating the
potential impact of this standard on our financial statement disclosures.
ASU 2025-06, Targeted Improvements to the Accounting for Internal-Use Software
This standard makes targeted improvements that clarify and modernize the accounting for costs related to internal-use software. ASU 2025-
06 is effective for interim and annual reporting periods beginning after December 15, 2027. We are currently evaluating the potential impact
of this standard on our financial statements and related disclosures.
9

-- 9 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
3. Income taxes
Provision for income taxes is based on the following:
For Three Months Ended 	For Nine Months Ended
September 30, 	September 30,
2025 	2024 	2025 	2024
Taxes calculated using the estimated annual effective tax rate 	$ 	249 	$ 	227 	$ 	614 	$ 	573
Discrete tax items 	(29) 	(35) 	(114) 	(73)
Provision for income taxes 	$ 	220 	$ 	192 	$ 	500 	$ 	500
Effective tax rate 	14 % 	12 % 	12 % 	12 %
On July 4, 2025, the U.S. government enacted the One Big Beautiful Bill Act (OBBBA). The OBBBA provides changes to U.S. federal tax law,
including expensing of U.S. research expenditures and eligible capital expenditures, increasing the U.S. CHIPS Act investment tax credit and
changing other tax provisions. The effects of the new law are reflected in the consolidated financial statements as of and for the periods
ended September 30, 2025.
The effective tax rate differs from the 21% U.S. statutory corporate tax rate due to the effect of U.S. tax benefits, including the effect of
OBBBA.
4. Valuation of debt and equity investments and certain liabilities
Investments measured at fair value
Money market funds, debt investments and mutual funds are stated at fair value, which is generally based on market prices or broker quotes.
We classify all debt investments as available-for-sale. See Fair-value considerations. Unrealized gains and losses are recorded as an
increase or decrease, net of taxes, in AOCI on our Consolidated Balance Sheets, and any credit losses are recorded as an allowance for
credit losses with an offset recognized in OI&E in our Consolidated Statements of Income.
Our mutual funds hold a variety of debt and equity investments intended to generate returns that offset changes in certain deferred
compensation liabilities. We record changes in the fair value of these mutual funds and the related deferred compensation liabilities in SG&A.
Other investments
Our other investments include equity-method investments and nonmarketable investments, which are not measured at fair value. These
investments consist of interests in venture capital funds and other nonmarketable securities. Gains and losses from equity-method
investments are recognized in OI&E based on our ownership share of the investee’s financial results. Nonmarketable securities are
measured at cost with adjustments for observable changes in price or impairments. Gains and losses on nonmarketable investments are
recognized in OI&E.
10

-- 10 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details of our investments are as follows:
September 30, 2025 	December 31, 2024
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Cash and Cash
Equivalents
Short-Term
Investments
Long-Term
Investments
Measured at fair value:
Money market funds 	$ 	737 $ 	— $ 	— $ 	762 $ 	— $ 	—
Corporate obligations 	738 	503 	— 	694 	796 	—
U.S. government and agency securities 	1,432 	1,198 	— 	752 	3,485 	—
Non-U.S. government and agency
securities 	50 	174 	— 	249 	99 	—
Mutual funds 	— 	— 	11 	— 	— 	11
Total 	2,957 	1,875 	11 	2,457 	4,380 	11
Other measurement basis:
Equity-method investments 	— 	— 	2 	— 	— 	8
Nonmarketable investments 	— 	— 	4 	— 	— 	4
Total 	— 	— 	6 	— 	— 	12
Cash on hand 	354 	— 	— 	743 	— 	—
Total 	$ 	3,311 $ 	1,875 $ 	17 $ 	3,200 $ 	4,380 $ 	23
As of September 30, 2025, and December 31, 2024, unrealized gains and losses associated with our debt investments were not material.
We did not recognize any credit losses related to debt investments for the first nine months of 2025 and 2024.
The following table presents the aggregate maturities of our debt investments as of September 30, 2025:
Fair Value
One year or less 	$ 	3,764
One to two years 	331
Proceeds from sales, redemptions and maturities of short-term debt investments were $1.26 billion and $2.70 billion for the third quarters of
2025 and 2024, respectively, and $5.20 billion and $8.46 billion for the first nine months of 2025 and 2024, respectively. Gross realized gains
and losses from these sales were not material.
Fair-value considerations
We measure and report certain financial assets and liabilities at fair value on a recurring basis. Fair value is defined as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date.
The three-level hierarchy described below indicates the inputs used to estimate fair-value measurements.
• Level 1 – Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities as of the measurement
date.
• Level 2 – Uses inputs other than Level 1 that are either directly or indirectly observable as of the measurement date through
correlation with market data. Inputs include quoted prices for similar assets and liabilities in active markets, quoted prices in markets
that are not active and models or other pricing methodologies that do not require significant judgment. We utilize a third-party data
service to provide Level 2 valuations, and we verify these valuations for reasonableness.
11

-- 11 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
• Level 3 – Uses inputs that are unobservable, supported by little or no market activity and reflect the use of significant management
judgment. As of September 30, 2025, and December 31, 2024, we had no Level 3 assets or liabilities.
The following are our assets and liabilities that were accounted for at fair value on a recurring basis. These tables do not include cash on
hand, assets held by our postretirement plans, or assets and liabilities that are measured at historical cost or any basis other than fair value.
September 30, 2025 	December 31, 2024
Level 1 	Level 2 	Total 	Level 1 	Level 2 	Total
Assets:
Money market funds 	$ 	737 $ 	— $ 	737 $ 	762 $ 	— $ 	762
Corporate obligations 	— 	1,241 	1,241 	— 	1,490 	1,490
U.S. government and agency securities 	2,231 	399 	2,630 	2,591 	1,646 	4,237
Non-U.S. government and agency securities 	— 	224 	224 	— 	348 	348
Mutual funds 	11 	— 	11 	11 	— 	11
Total assets 	$ 	2,979 $ 	1,864 $ 	4,843 $ 	3,364 $ 	3,484 $ 	6,848
Liabilities:
Deferred compensation 	$ 	475 $ 	— $ 	475 $ 	443 $ 	— $ 	443
Total liabilities 	$ 	475 $ 	— $ 	475 $ 	443 $ 	— $ 	443
5. Postretirement benefit plans
Expenses related to defined benefit and retiree health care benefit plans are as follows:
U.S. Defined Benefit 	U.S. Retiree Health Care 	Non-U.S. Defined Benefit
For Three Months Ended September 30, 	2025 	2024 	2025 	2024 	2025 	2024
Service cost 	$ 	1 $ 	2 $ 	— $ 	— $ 	4 $ 	4
Interest cost 	6 	7 	3 	4 	16 	15
Expected return on plan assets 	(3) 	(7) 	(2) 	(4) 	(20) 	(22)
Recognized net actuarial losses (gains) 	1 	1 	— 	(1) 	1 	3
Amortization of prior service cost (credit) 	— 	— 	— 	— 	— 	1
Net periodic benefit costs (credits) 	5 	3 	1 	(1) 	1 	1
Settlement losses 	4 	— 	— 	— 	— 	—
Total, including other postretirement losses (gains) $ 	9 $ 	3 $ 	1 $ 	(1) $ 	1 $ 	1
U.S. Defined Benefit 	U.S. Retiree Health Care 	Non-U.S. Defined Benefit
For Nine Months Ended September 30, 	2025 	2024 	2025 	2024 	2025 	2024
Service cost 	$ 	5 $ 	6 $ 	1 $ 	1 $ 	11 $ 	12
Interest cost 	19 	19 	9 	10 	45 	42
Expected return on plan assets 	(13) 	(18) 	(8) 	(13) 	(55) 	(60)
Recognized net actuarial losses (gains) 	5 	3 	(1) 	(2) 	3 	9
Amortization of prior service cost (credit) 	— 	— 	— 	— 	— 	1
Net periodic benefit costs (credits) 	16 	10 	1 	(4) 	4 	4
Settlement losses 	7 	— 	— 	— 	— 	—
Total, including other postretirement losses (gains) $ 	23 $ 	10 $ 	1 $ 	(4) $ 	4 $ 	4
12

-- 12 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
6. Debt and lines of credit
Short-term borrowings
We maintain a line of credit to provide additional liquidity through bank loans and, if necessary, to support commercial paper borrowings. As
of September 30, 2025, the aforementioned line of credit was a variable-rate, revolving credit facility from a consortium of investment-grade
banks that allows us to borrow up to $1 billion until March 2026. The interest rate on borrowings under this credit facility, if drawn, is indexed
to the applicable Term Secured Overnight Financing Rate (Term SOFR). As of September 30, 2025, our credit facility was undrawn, and we
had no commercial paper outstanding.
Long-term debt
In May 2025, we issued two series of senior unsecured notes for an aggregate principal amount of $1.20 billion, consisting of $550 million of
4.50% notes due in 2030 and $650 million of 5.10% notes due in 2035. We incurred $6 million of issuance and other related costs. The
proceeds of the offering were $1.20 billion, net of the original issuance discounts, which will be used for general corporate purposes.
In March 2025, we retired $750 million of maturing debt.
Long-term debt outstanding is as follows:
September 30, 	December 31,
2025 	2024
Notes due 2025 at 1.375% 	$ 	— $ 	750
Notes due 2026 at 1.125% 	500 	500
Notes due 2027 at 4.60% 	650 	650
Notes due 2027 at 2.90% 	500 	500
Notes due 2028 at 4.60% 	700 	700
Notes due 2029 at 4.60% 	650 	650
Notes due 2029 at 2.25% 	750 	750
Notes due 2030 at 1.75% 	750 	750
Notes due 2030 at 4.50% 	550 	—
Notes due 2031 at 1.90% 	500 	500
Notes due 2032 at 3.65% 	400 	400
Notes due 2033 at 4.90% 	950 	950
Notes due 2034 at 4.85% 	600 	600
Notes due 2035 at 5.10% 	650 	—
Notes due 2039 at 3.875% 	750 	750
Notes due 2048 at 4.15% 	1,500 	1,500
Notes due 2051 at 2.70% 	500 	500
Notes due 2052 at 4.10% 	300 	300
Notes due 2053 at 5.00% 	650 	650
Notes due 2054 at 5.15% 	750 	750
Notes due 2063 at 5.05% 	1,550 	1,550
Total debt 	14,150 	13,700
Net unamortized discounts, premiums and issuance costs 	(104) 	(104)
Total debt, including net unamortized discounts, premiums and issuance costs 	14,046 	13,596
Current portion of long-term debt 	(500) 	(750)
Long-term debt 	$ 	13,546 $ 	12,846
13

-- 13 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Interest and debt expense was $141 million and $131 million for the third quarters of 2025 and 2024, respectively, and $402 million and $378
million for the first nine months of 2025 and 2024, respectively. This was net of the amortized discounts, premiums and issuance and other
related costs. Capitalized interest was $3 million and $5 million for the third quarters of 2025 and 2024, respectively, and $9 million and
$16 million for the first nine months of 2025 and 2024, respectively.
7. Stockholders’ equity
Changes in equity are as follows:
Common Stock Paid-in Capital Retained
Earnings
Treasury
Common Stock 	AOCI
Balance, December 31, 2024 	$ 	1,741 $ 	3,935 $ 	52,262 $ 	(40,895) $ 	(140)
2025
Net income 	— 	— 	1,179 	— 	—
Dividends declared and paid ($1.36 per share) 	— 	— 	(1,238) 	— 	—
Common stock issued for stock-based awards 	— 	8 	— 	110 	—
Stock repurchases 	— 	— 	— 	(657) 	—
Stock compensation 	— 	116 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	(7)
Dividend equivalents on RSUs 	— 	— 	(7) 	— 	—
Other 	— 	(1) 	— 	— 	—
Balance, March 31, 2025 	1,741 	4,058 	52,196 	(41,442) 	(147)
Net income 	— 	— 	1,295 	— 	—
Dividends declared and paid ($1.36 per share) 	— 	— 	(1,235) 	— 	—
Common stock issued for stock-based awards 	— 	59 	— 	56 	—
Stock repurchases 	— 	— 	— 	(290) 	—
Stock compensation 	— 	129 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	(9)
Dividend equivalents on RSUs 	— 	— 	(7) 	— 	—
Other 	— 	(1) 	— 	— 	—
Balance, June 30, 2025 	1,741 	4,245 	52,249 	(41,676) 	(156)
Net income 	— 	— 	1,364 	— 	—
Dividends declared and paid ($1.36 per share) 	— 	— 	(1,236) 	— 	—
Common stock issued for stock-based awards 	— 	72 	— 	53 	—
Stock repurchases 	— 	— 	— 	(121) 	—
Stock compensation 	— 	93 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	7
Dividend equivalents on RSUs 	— 	— 	(7) 	— 	—
Other 	— 	— 	(1) 	— 	—
Balance, September 30, 2025 	$ 	1,741 $ 	4,410 $ 	52,369 $ 	(41,744) $ 	(149)
14

-- 14 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Common Stock Paid-in Capital Retained
Earnings
Treasury
Common Stock 	AOCI
Balance, December 31, 2023 	$ 	1,741 $ 	3,362 $ 	52,283 $ 	(40,284) $ 	(205)
2024
Net income 	— 	— 	1,105 	— 	—
Dividends declared and paid ($1.30 per share) 	— 	— 	(1,183) 	— 	—
Common stock issued for stock-based awards 	— 	(29) 	— 	94 	—
Stock repurchases 	— 	— 	— 	(3) 	—
Stock compensation 	— 	106 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	2
Dividend equivalents on RSUs 	— 	— 	(7) 	— 	—
Other 	— 	— 	1 	— 	—
Balance, March 31, 2024 	1,741 	3,439 	52,199 	(40,193) 	(203)
Net income 	— 	— 	1,127 	— 	—
Dividends declared and paid ($1.30 per share) 	— 	— 	(1,185) 	— 	—
Common stock issued for stock-based awards 	— 	111 	— 	137 	—
Stock repurchases 	— 	— 	— 	(72) 	—
Stock compensation 	— 	116 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	3
Dividend equivalents on RSUs 	— 	— 	(6) 	— 	—
Balance, June 30, 2024 	1,741 	3,666 	52,135 	(40,128) 	(200)
Net income 	— 	— 	1,362 	— 	—
Dividends declared and paid ($1.30 per share) 	— 	— 	(1,187) 	— 	—
Common stock issued for stock-based awards 	— 	62 	— 	55 	—
Stock repurchases 	— 	— 	— 	(322) 	—
Stock compensation 	— 	87 	— 	— 	—
Other comprehensive income (loss), net of taxes 	— 	— 	— 	— 	5
Dividend equivalents on RSUs 	— 	— 	(6) 	— 	—
Other 	— 	(2) 	— 	— 	—
Balance, September 30, 2024 	$ 	1,741 $ 	3,813 $ 	52,304 $ 	(40,395) $ 	(195)
8. Contingencies
Indemnification guarantees
We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal,
infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.
15

-- 15 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Warranty costs/product liabilities
Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the
buyer. Product claim consideration may exceed the price of our products. Historically, we have experienced a low rate of payments on
product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse
effect on our consolidated financial statements. We accrue for known product-related claims if a loss is probable and can be reasonably
estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability.
General
We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we
believe that the results of these proceedings will not have a material adverse effect on our consolidated financial statements.
9. Supplemental financial information
Restructuring charges/other
During the third quarter and first nine months of 2025, we recognized $85 million of restructuring charges related to efforts to drive
operational efficiencies to support our long-term strategy, including the planned closures of our two remaining factories with 150mm
production. The restructuring charges are attributable to severance and benefit costs and are included in Other for segment reporting
purposes.
Prepaid expenses and other current assets
September 30, 	December 31,
2025 	2024
CHIPS Act incentives 	$ 	1,501 $ 	904
Other 	298 	296
Total 	$ 	1,799 $ 	1,200
Other long-term assets
September 30, 	December 31,
2025 	2024
CHIPS Act incentives 	$ 	1,734 $ 	2,246
Other 	1,107 	1,102
Total 	$ 	2,841 $ 	3,348
16

-- 16 of 34 --

TEXAS INSTRUMENTS INCORPORATED AND SUBSIDIARIES
Details on amounts reclassified out of accumulated other comprehensive income (loss), net of taxes, to net income
Our Consolidated Statements of Comprehensive Income include items that have been recognized within net income during the third quarters
and first nine months of 2025 and 2024. The table below details where these transactions are recorded in our Consolidated Statements of
Income.
For Three Months Ended 	For Nine Months Ended
Impact to Related Statement of Income
Lines
September 30, 	September 30,
2025 	2024 	2025 	2024
Net actuarial losses of defined benefit
plans:
Recognized net actuarial losses and
settlement losses (a) 	$ 	6 $ 	3 $ 	14 $ 	10 Decrease to OI&E
Tax effect 	(1) 	(1) 	(3) 	(3)
Decrease to provision for income
taxes
Recognized within net income, net of
taxes 	$ 	5 $ 	2 $ 	11 $ 	7 Decrease to net income
Prior service cost (credit) of defined
benefit plans:
Amortization of prior service cost (credit)
(a) 	$ 	— $ 	1 $ 	— $ 	1 Decrease (increase) to OI&E
Tax effect 	— 	— 	— 	—
(Decrease) increase to provision for
income taxes
Recognized within net income, net of
taxes 	$ 	— $ 	1 $ 	— $ 	1 Decrease (increase) to net income
(a) Detailed in Note 5
Effect on shares outstanding and treasury shares
The following table reflects the changes in treasury shares:
2025
Balance, January 1 	830
Repurchases 	4
Shares issued for stock compensation 	(2)
Balance, March 31 	832
Repurchases 	1
Shares issued for stock compensation 	(1)
Balance, June 30 	832
Repurchases 	1
Shares issued for stock compensation 	(1)
Balance, September 30 	832
17

-- 17 of 34 --

ITEM 2. Management’s discussion and analysis of financial condition and results of operations
Overview
We design and manufacture semiconductors that we sell to electronics designers and manufacturers all over the world. Technology is the
foundation of our company, but ultimately, our objective and the best metric for owners to measure our progress is through the growth of free
cash flow per share over the long term.
Our strategy to maximize long-term free cash flow per share growth has three elements:
1. A great business model that is focused on analog and embedded processing products and built around four sustainable competitive
advantages. The four sustainable competitive advantages are powerful in combination and provide tangible benefits:
(a) A strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain.
(b) A broad portfolio of analog and embedded processing products that offers more opportunity per customer and more value for
our investments.
(c) The reach of our market channels that gives access to more customers and more of their design projects, leading to the
opportunity to sell more of our products into each design and gives us better insight and knowledge of customer needs.
(d) Diversity and longevity of our products, markets and customer positions that provide less single point dependency and
longer returns on our investments.
Together, these competitive advantages help position TI in a unique class of companies capable of generating and returning
significant amounts of cash for our owners. We make our investments with an eye towards long-term strengthening and leveraging of
these advantages.
2. Discipline in allocating capital to the best opportunities. This spans how we select R&D projects, develop new capabilities, invest in
manufacturing capacity or how we think about acquisitions and returning cash to our owners.
3. Efficiency, which means constantly striving for more output for every dollar spent.
We believe that our business model with the combined effect of our four competitive advantages sets TI apart from our peers and will for a
long time to come. We will invest to strengthen our competitive advantages, be disciplined in capital allocation and stay diligent in our pursuit
of efficiencies. Finally, we will remain focused on the belief that long-term growth of free cash flow per share is the ultimate measure to
generate value.
Market and business characteristics
Markets for our products
The end markets for our products are industrial, automotive, personal electronics, enterprise systems and communications equipment. See
our 2024 Form 10-K for more information, where we also report calculators and other.
Market cycle
The “semiconductor cycle” refers to the ebb and flow of supply and demand and the building and depleting of inventories. The semiconductor
market historically has been characterized by periods of tight supply caused by strengthening demand and/or insufficient manufacturing
capacity, followed by periods of surplus inventory caused by weakening demand and/or excess manufacturing capacity. These are typically
referred to as upturns and downturns in the semiconductor cycle. Semiconductor cycles are affected by the significant time and money
required to build and maintain semiconductor manufacturing facilities.
18

-- 18 of 34 --

Seasonality
Our revenue is subject to some seasonal variation. Historically, our sequential revenue growth rate tends to be weaker in the first and fourth
quarters when compared with the second and third quarters.
Manufacturing
We invest to make manufacturing and technology a core competitive advantage. The strategic decision to own our manufacturing, process
and packaging technology provides us with tangible benefits of lower manufacturing costs and greater control of our supply chain and
provides our customers with geopolitically dependable capacity. We own and operate both wafer fabrication and assembly/test facilities in
North America, Asia, Japan and Europe. We have focused on creating a competitive structural cost advantage by investing in our 300mm
wafer production, which describes the diameter of the wafer on which our chips are produced, and costs about 40% less than a chip built on
a 200mm wafer. In addition, we selectively use capacity of outside suppliers, commonly known as foundries and subcontractors.
We continue to invest to strengthen our competitive advantage in manufacturing and technology as part of our long-term capacity plan. We
are now mostly through a six-year elevated capital expenditures cycle that, when completed, will uniquely position TI to deliver dependable,
low-cost 300mm capacity, scalability of capital expenditures, including capacity modularity, and free cash flow per share growth across a
range of market conditions.
With our planned capacity expansions to support demand over time, we expect our internal sourcing to continue to increase. As our Lehi,
Utah, manufacturing facility is in the early ramping stages, Embedded Processing is disproportionately impacted by costs associated with the
site’s capacity expansion. We expect to continue to maintain sufficient internal manufacturing capacity to meet the majority of our production
needs and to obtain manufacturing equipment to support new technology developments and revenue growth.
In 2020, we announced a multi-year plan to close our two remaining factories with 150mm production, which are more than 50 years old and
located in Sherman and Dallas, Texas. Production is transitioning from these sites to our more advanced and cost-effective 300mm wafer
fabrication facilities.
Inventory
Our objectives for inventory are to maintain high levels of customer service, maintain dependable and competitive lead times, minimize
inventory obsolescence and improve manufacturing asset utilization. To meet these objectives and to allow greater flexibility in periods of
high demand, our strategy is to build ahead of demand our broad-based products that are used across a diverse set of applications and
customers and have low risk of obsolescence. Inventory levels will vary based on market conditions and seasonality. We adjust factory
loadings as needed to execute on this inventory strategy.
Results of operations
Management’s discussion and analysis of financial condition and results of operations (MD&A) should be read in conjunction with the
financial statements and the related notes that appear elsewhere in this document. In the following discussion of our results of operations:
• Our segments represent groups of similar products that are combined on the basis of similar design and development requirements,
product characteristics, manufacturing processes and distribution channels, and how management allocates resources and measures
results. See Note 1 to the financial statements for more information regarding our segments.
• When we discuss our results:
◦ Unless otherwise noted, changes in our revenue are attributable to changes in customer demand, which are evidenced by
fluctuations in shipment volumes.
◦ New products do not tend to have a significant impact on our revenue in any given period because we sell such a large
number of products.
◦ From time to time, our revenue and gross profit are affected by changes in demand for higher-priced or lower-priced
products, which we refer to as changes in the “mix” of products shipped.
19

-- 19 of 34 --

◦ Because we own much of our manufacturing capacity, a significant portion of our operating cost is fixed. When factory
loadings decrease, our fixed costs are spread over reduced output and, absent other circumstances, our profit margins
decrease. Conversely, as factory loadings increase, our fixed costs are spread over increased output and, absent other
circumstances, our profit margins increase.
• For an explanation of free cash flow, see the Non-GAAP financial information section.
• All dollar amounts in the tables are stated in millions of U.S. dollars.
Performance summary
Our third quarter revenue was $4.74 billion, net income was $1.36 billion and earnings per share (EPS) were $1.48.
Revenue increased 7% sequentially and 14% from the same quarter a year ago with growth across all end markets.
Our cash flow from operations of $6.9 billion for the trailing 12 months again underscored the strength of our business model, the quality of
our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $2.4 billion.
Over the past 12 months we invested $3.9 billion in R&D and SG&A, invested $4.8 billion in capital expenditures and returned $6.6 billion to
shareholders.
Macroeconomic factors
We believe trade dynamics and geopolitics are disrupting and reshaping global supply chains and affecting customer order behavior. Our
global manufacturing capabilities enable us to support our customers’ needs. The overall semiconductor market recovery is continuing,
though at a slower pace than prior upturns, likely related to broader macroeconomic dynamics and overall uncertainty.
U.S. legislative update
On July 4, 2025, the U.S. government enacted the One Big Beautiful Bill Act (OBBBA). The OBBBA provides changes to U.S. federal tax law,
including expensing of U.S. research expenditures and eligible capital expenditures, increasing the U.S. CHIPS and Science Act (CHIPS Act)
investment tax credit (ITC) and changing other tax provisions. The effect of the new law results in a higher effective tax rate in the third
quarter and full year 2025. For 2026 and beyond, we expect the effective tax rate to be lower than it would have been under prior tax law.
Additionally, we expect tax-related cash payments to be lower for the next several years as a result of the changes.
Details of financial results – third quarter 2025 compared with third quarter 2024
Revenue of $4.74 billion increased $591 million, or 14%, due to higher revenue from increased demand in our Analog segment and, to a
lesser extent, in our Embedded Processing segment, which were both impacted by the macroeconomic factors discussed above.
Gross profit of $2.72 billion was up $249 million, or 10%, due to higher revenue, partially offset by higher manufacturing costs associated with
our planned capacity expansions. As a percentage of revenue, gross profit decreased to 57.4% from 59.6%.
Operating expenses (R&D and SG&A) were $975 million compared with $920 million.
Restructuring charges/other was $85 million related to efforts to drive operational efficiencies to support our long-term strategy, including the
planned closures of our two remaining factories with 150mm production.
Operating profit was $1.66 billion, or 35.1% of revenue, compared with $1.55 billion, or 37.4% of revenue. This change was primarily due to
higher revenue, partially offset by higher manufacturing costs.
OI&E was $62 million of income compared with $131 million of income. This decrease was due to lower interest income.
20

-- 20 of 34 --

Interest and debt expense of $141 million increased $10 million. See Note 6 to the financial statements.
Our provision for income taxes was $220 million compared with $192 million. This increase was primarily due to changes in the effect of U.S.
tax benefits, including the effect of OBBBA, lower discrete tax benefits and higher income before income taxes. Our effective tax rate, which
includes discrete tax items, was 14% compared with 12%.
Net income was $1.36 billion in both periods. EPS was $1.48 compared with $1.47.
Third quarter 2025 segment results
Our segment results compared with the year-ago quarter are as follows:
Analog (includes Power and Signal Chain product lines)
Q3 2025 	Q3 2024 	Change
Revenue 	$ 	3,729 	$ 	3,223 	16 %
Operating profit 	1,486 	1,316 	13 %
Operating profit % of revenue 	39.8 % 	40.8 %
Analog revenue increased in both product lines, led by Signal Chain, due to higher demand, which was impacted by the macroeconomic
factors discussed above. Operating profit increased primarily due to higher revenue, partially offset by higher manufacturing costs and
operating expenses.
Embedded Processing (includes microcontrollers and processors)
Q3 2025 	Q3 2024 	Change
Revenue 	$ 	709 	$ 	653 	9 %
Operating profit 	108 	109 	(1)%
Operating profit % of revenue 	15.2 % 	16.7 %
Embedded Processing revenue increased due to higher demand, which was impacted by the macroeconomic factors discussed above.
Operating profit was about even due to higher manufacturing costs and operating expenses, offset by higher revenue.
Other (includes DLP products, calculators and custom ASIC products)
Q3 2025 	Q3 2024 	Change
Revenue 	$ 	304 	$ 	275 	11 %
Operating profit * 	69 	129 	(47)%
Operating profit % of revenue 	22.7 % 	46.9 %
* Includes Restructuring charges/other
Other revenue increased $29 million, and operating profit decreased $60 million.
Details of financial results – first nine months of 2025 compared with first nine months of 2024
Revenue of $13.26 billion increased $1.63 billion, or 14%, due to higher revenue from increased demand in our Analog segment and, to a
lesser extent, in our Embedded Processing segment, which were both impacted by the macroeconomic factors discussed above.
Gross profit of $7.61 billion was up $831 million, or 12%, due to higher revenue. Our gross profit was also impacted by higher manufacturing
costs associated with our planned capacity expansions, partially offset by reduced costs related to increased factory loadings. As a
percentage of revenue, gross profit decreased to 57.4% from 58.3%.
Operating expenses were $2.98 billion compared with $2.82 billion.
®
21

-- 21 of 34 --

Restructuring charges/other was $85 million related to efforts to drive operational efficiencies to support our long-term strategy, including the
planned closures of our two remaining factories with 150mm production, compared with a credit of $124 million primarily due to a gain on the
sale of a property during 2024.
Operating profit was $4.55 billion, or 34.3% of revenue, compared with $4.09 billion, or 35.1% of revenue. This change was primarily due to
higher revenue and associated gross profit, partially offset by higher operating expenses.
OI&E was $190 million of income compared with $384 million of income. This decrease was due to lower interest income.
Interest and debt expense of $402 million increased $24 million.
Our provision for income taxes was $500 million in both periods. This includes an increase in taxes from higher income before income taxes
and changes in the effect of U.S. tax benefits, including the effect of OBBBA, offset by higher discrete tax benefits of $41 million, primarily
related to our non-U.S. operations. Our effective tax rate, which includes discrete tax items, was 12% in both periods.
Net income was $3.84 billion compared with $3.59 billion. EPS was $4.18 compared with $3.89.
Year-to-date segment results
Our segment results compared with the year-ago period are as follows:
Analog
YTD 2025 	YTD 2024 	Change
Revenue 	$ 	10,391 	$ 	8,987 	16 %
Operating profit 	4,017 	3,371 	19 %
Operating profit % of revenue 	38.7 % 	37.5 %
Analog revenue increased in both product lines, led by Power, due to higher demand, which was impacted by the macroeconomic factors
discussed above. Operating profit increased primarily due to higher revenue and associated gross profit, partially offset by higher operating
expenses.
Embedded Processing
YTD 2025 	YTD 2024 	Change
Revenue 	$ 	2,035 	$ 	1,920 	6 %
Operating profit 	233 	294 	(21)%
Operating profit % of revenue 	11.4 % 	15.3 %
Embedded Processing revenue increased due to higher demand, which was impacted by the macroeconomic factors discussed above.
Operating profit decreased primarily due to higher manufacturing costs and operating expenses, partially offset by higher revenue.
Other
YTD 2025 	YTD 2024 	Change
Revenue 	$ 	833 	$ 	727 	15 %
Operating profit * 	300 	423 	(29)%
Operating profit % of revenue 	36.0 % 	58.2 %
* Includes Restructuring charges/other
Other revenue increased $106 million, and operating profit decreased $123 million.
22

-- 22 of 34 --

Financial condition
At the end of the third quarter of 2025, total cash (cash and cash equivalents plus short-term investments) was $5.19 billion, a decrease of
$2.39 billion from the end of 2024.
Accounts receivable were $2.06 billion, an increase of $343 million compared with the end of 2024. Days sales outstanding were 39 for both
the third quarter of 2025 and at the end of 2024.
Inventory was $4.83 billion, an increase of $302 million from the end of 2024. Days of inventory for the third quarter of 2025 were 215
compared with 241 at the end of 2024, which reflects the continued execution of our inventory strategy. As our current inventory levels align
with our objectives, we expect to moderate factory loadings accordingly.
Liquidity and capital resources
Our primary source of liquidity is cash flow from operations. Additional sources of liquidity are cash and cash equivalents, short-term
investments and access to debt markets. We also have a variable-rate, revolving credit facility. As of September 30, 2025, our credit facility
was undrawn, and we had no commercial paper outstanding. Cash flows from operating activities for the first nine months of 2025 were
$4.90 billion, an increase of $579 million from the year-ago period primarily due to higher net income and non-cash items, partially offset by
higher cash used for working capital. Cash flows from operating activities for the first nine months of 2025 and 2024 includes cash benefits of
$246 million and $532 million, respectively, from the CHIPS Act ITC used to reduce income taxes payable.
Investing activities for the first nine months of 2025 used $763 million compared with $3.82 billion in the year-ago period. Capital
expenditures were $3.63 billion in both periods and were primarily for semiconductor manufacturing equipment and facilities. For the first nine
months of 2025, we received proceeds of $335 million from CHIPS Act incentives, including $75 million in direct funding. Short-term
investments provided cash of $2.55 billion compared with $346 million of cash used in the year-ago period.
We are now mostly through a six-year elevated capital expenditures cycle, and consistent with our capital management strategy, we are
currently evaluating our capital expenditure levels to determine if they will remain at elevated levels in 2026 and beyond, dependent on
revenue and growth expectations. We expect to continue benefiting from the CHIPS Act, including the 25% ITC on qualifying manufacturing
investments that increases to 35% for assets placed in service after December 31, 2025, and direct funding of up to $1.6 billion for our three
large-scale 300mm wafer fabs located in Sherman, Texas, and Lehi, Utah.
In September 2025, we announced we would increase our quarterly cash dividend by 4% to $1.42 per share, marking 22 consecutive years
of dividend increases.
Financing activities for the first nine months of 2025 used $4.03 billion compared with $879 million in the year-ago period. We received net
proceeds of $1.20 billion from the issuance of fixed-rate, long-term debt and retired maturing debt of $750 million. In the year-ago period, we
received net proceeds of $2.98 billion from the issuance of fixed-rate, long-term debt and retired maturing debt of $300 million. Dividends
paid were $3.71 billion compared with $3.56 billion in the year-ago period, reflecting an increased dividend rate. We used $1.07 billion to
repurchase 6.1 million shares of our common stock compared with $392 million to repurchase 2.0 million shares in the year-ago period.
Employee exercises of stock options provided cash proceeds of $358 million compared with $430 million in the year-ago period.
We had $3.31 billion of cash and cash equivalents and $1.88 billion of short-term investments as of September 30, 2025. We believe we
have the necessary financial resources and operating plans to fund our working capital needs, capital expenditures, dividend and debt-
related payments, and other business requirements for at least the next 12 months.
23

-- 23 of 34 --

Non-GAAP financial information
This MD&A includes references to free cash flow and ratios based on that measure. These are financial measures that were not prepared in
accordance with generally accepted accounting principles in the United States (GAAP). Free cash flow is calculated as cash flows from
operating activities (also referred to as cash flow from operations) less capital expenditures, plus proceeds from CHIPS Act incentives.
We believe that free cash flow and the associated ratios provide insight into our liquidity, our cash-generating capability and the amount of
cash potentially available to return to shareholders, as well as insight into our financial performance. These non-GAAP measures are
supplemental to the comparable GAAP measures.
Reconciliation to the most directly comparable GAAP measures is provided in the table below.
For 12 Months Ended
September 30,
2025 	2024 	Change
Cash flow from operations (GAAP) * 	$ 	6,897 	$ 	6,244 	10 %
Capital expenditures 	(4,817) 	(4,776)
Proceeds from CHIPS Act incentives 	335 	—
Free cash flow (non-GAAP) 	$ 	2,415 	$ 	1,468 	65 %
Revenue 	$ 	17,266 	$ 	15,711
Cash flow from operations as a percentage of revenue (GAAP) 	39.9 % 	39.7 %
Free cash flow as a percentage of revenue (non-GAAP) 	14.0 % 	9.3 %
* Includes cash benefits of $302 million and $532 million from the CHIPS Act ITC used to reduce income taxes payable for the twelve months
ended September 30, 2025 and 2024, respectively.
24

-- 24 of 34 --

ITEM 4. Controls and procedures
An evaluation as of the end of the period covered by this report was carried out under the supervision and with the participation of
management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our
disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934). Based upon
that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that those disclosure controls and procedures were
effective. In addition, there has been no change in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f)
under the Securities Exchange Act of 1934) that occurred during the period covered by this report that has materially affected, or is
reasonably likely to materially affect, our internal control over financial reporting.
25

-- 25 of 34 --

PART II – OTHER INFORMATION
ITEM 1. Legal proceedings
Information with respect to legal proceedings can be found in Note 8 to the financial statements.
Pursuant to SEC regulation, we have elected to use a disclosure threshold of $1 million in monetary sanctions for environmental proceedings
involving a governmental authority.
ITEM 1A. Risk factors
Information concerning our risk factors is contained in Item 1A of our Form 10-K for the year ended December 31, 2024, and is incorporated
by reference herein.
ITEM 2. Unregistered sales of equity securities and use of proceeds
The following table contains information regarding our purchases of our common stock during the quarter.
ISSUER PURCHASES OF EQUITY SECURITIES
Period Total Number of Shares
Purchased
Average Price
Paid per Share
Total Number of Shares
Purchased as Part of
Publicly Announced
Plans or Programs (a)
Approximate Dollar Value of
Shares that May Yet Be
Purchased Under the Plans
or Programs (a)
July 1 - 31, 2025 	34,171 $ 	187.28 	34,171 $ 19.31 billion
August 1 - 31, 2025 	191,418 	189.84 	191,418 	19.27 billion
September 1 - 30, 2025 	433,795 	181.71 	433,795 	19.19 billion (b)
Total 	659,384 	659,384
(a) All open-market purchases during the quarter were made under the authorizations from our board of directors to purchase up to $12.0
billion and $15.0 billion of additional shares of TI common stock announced September 20, 2018, and September 15, 2022, respectively.
(b) As of September 30, 2025, this amount consisted of the remaining portion of the $12.0 billion authorized in September 2018 and the
$15.0 billion authorized in September 2022. No expiration date has been specified for these authorizations.
26

-- 26 of 34 --

ITEM 6. Exhibits
Designation of Exhibits in
This Report 	Description of Exhibit
3(a) Restated Certificate of Incorporation of the Registrant, dated April 18, 1985, as amended (incorporated by reference
to Exhibit 3(a) of the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014).
3(b) By-Laws of the Registrant (incorporated by reference to Exhibit 3 of the Registrant’s Current Report on Form 8-K
filed January 26, 2022).
31(a) 	Certification of Chief Executive Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
31(b) 	Certification of Chief Financial Officer of Periodic Report Pursuant to Rule 13a-14(a) or Rule 15d-14(a).†
32(a) 	Certification by Chief Executive Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
32(b) 	Certification by Chief Financial Officer of Periodic Report Pursuant to 18 U.S.C. Section 1350.†
101.ins XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL
tags are embedded within the Inline XBRL document.†
101.def 	XBRL Taxonomy Extension Definition Linkbase Document.†
101.sch 	XBRL Taxonomy Extension Schema Document.†
101.cal 	XBRL Taxonomy Extension Calculation Linkbase Document.†
101.lab 	XBRL Taxonomy Extension Label Linkbase Document.†
101.pre 	XBRL Taxonomy Extension Presentation Linkbase Document.†
104 	Cover Page Interactive Data File (embedded within the Inline XBRL document).†
† Filed or furnished herewith.
27

-- 27 of 34 --

Notice regarding forward-looking statements
This report includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities
Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as TI or its management
“believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements
herein that describe TI’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in
forward-looking statements.
We urge you to carefully consider the following important factors that could cause actual results to differ materially from the expectations of TI
or our management:
• Economic, social and political conditions, and natural events in the countries in which we, our customers or our suppliers operate,
including global trade policies;
• Market demand for semiconductors, particularly in the industrial and automotive markets, and customer demand that differs from
forecasts;
• Our ability to compete in products and prices in an intensely competitive industry;
• Evolving cybersecurity and other threats relating to our information technology systems or those of our customers, suppliers and
other third parties;
• Our ability to successfully implement and realize opportunities from strategic, business and organizational changes, or our ability to
realize our expectations regarding the amount and timing of associated restructuring charges and cost savings;
• Our ability to develop, manufacture and market innovative products in a rapidly changing technological environment, our timely
implementation of new manufacturing technologies and installation of manufacturing equipment, and our ability to realize expected
returns on significant investments in manufacturing capacity;
• Availability and cost of key materials, utilities, manufacturing equipment, third-party manufacturing services and manufacturing
technology;
• Our ability to recruit and retain skilled personnel and effectively manage key employee succession;
• Product liability, warranty or other claims relating to our products, software, manufacturing, delivery, services, design or
communications, or recalls by our customers for a product containing one of our parts;
• Compliance with or changes in the complex laws, rules and regulations to which we are or may become subject, or actions of
enforcement authorities, that restrict our ability to operate our business or subject us to fines, penalties or other legal liability;
• Changes in tax law and accounting standards that impact the tax rate applicable to us, the jurisdictions in which profits are
determined to be earned and taxed, adverse resolution of tax audits, increases in tariff rates, and the ability to realize deferred tax
assets;
• Financial difficulties of our distributors or semiconductor distributors’ promotion of competing product lines to our detriment; or
disputes with current or former distributors;
• Losses or curtailments of purchases from key customers or the timing and amount of customer inventory adjustments;
• Our ability to maintain or improve profit margins, including our ability to utilize our manufacturing facilities at sufficient levels to cover
our fixed operating costs, in an intensely competitive and cyclical industry and changing regulatory environment;
• Our ability to maintain and enforce a strong intellectual property portfolio and maintain freedom of operation in all jurisdictions where
we conduct business; or our exposure to infringement claims;
• Instability in the global credit and financial markets; and
• Impairments of our non-financial assets.
28

-- 28 of 34 --

For a more detailed discussion of these factors, see the Risk factors discussion in Item 1A of our most recent Form 10-K. The forward-
looking statements included in this report are made only as of the date of this report, and we undertake no obligation to update the forward-
looking statements to reflect subsequent events or circumstances. If we do update any forward-looking statement, you should not infer that
we will make additional updates with respect to that statement or any other forward-looking statement.
29

-- 29 of 34 --

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
TEXAS INSTRUMENTS INCORPORATED
By: 	/s/ Rafael R. Lizardi
Rafael R. Lizardi, Senior Vice President and Chief
Financial Officer
Date: October 23, 2025

-- 30 of 34 --

Exhibit 31(a)
CERTIFICATIONS
I, Haviv Ilan, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. 	The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
Date: October 23, 2025
/s/ Haviv Ilan
Haviv Ilan
President and
Chief Executive Officer

-- 31 of 34 --

Exhibit 31(b)
CERTIFICATIONS
I, Rafael R. Lizardi, certify that:
1. 	I have reviewed this report on Form 10-Q of Texas Instruments Incorporated;
2. 	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;
3. 	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. 	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and
(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5. 	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the
equivalent functions):
(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
and
(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
Date: October 23, 2025
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 32 of 34 --

Exhibit 32(a)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned,
Haviv Ilan, President and Chief Executive Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that, to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2025, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Company.
Dated: October 23, 2025
/s/ Haviv Ilan
Haviv Ilan
President and
Chief Executive Officer

-- 33 of 34 --

Exhibit 32(b)
Certification of Periodic Report
Pursuant to 18 U.S.C. Section 1350
For purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned,
Rafael R. Lizardi, Senior Vice President and Chief Financial Officer of Texas Instruments Incorporated (the “Company”), hereby certifies that,
to his knowledge:
(i) the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2025, as filed with the Securities and
Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of
the Company.
Dated: October 23, 2025
/s/ Rafael R. Lizardi
Rafael R. Lizardi
Senior Vice President and
Chief Financial Officer

-- 34 of 34 --